Form 4: Centessa Pharmaceuticals Executive Gregory Weinhoff Reports Share Disposal for Tax Obligations and Option Grant

Gregory Weinhoff, Chief Business Officer of Centessa Pharmaceuticals, reports disposing of shares to cover tax obligations and receiving a new share option grant.

Summary

• On February 1, 2025, Gregory M. Weinhoff, Chief Business Officer of Centessa Pharmaceuticals plc, disposed of 14,267 ordinary shares to cover tax withholding obligations related to the vesting of restricted share units at a price of $16.92 per share.
• Following this transaction, Weinhoff directly owns 145,515 ordinary shares.
• On February 3, 2025, Weinhoff was granted a share option to purchase 100,000 ordinary shares at an exercise price of $16.90, which vests monthly starting March 3, 2025, and expires on February 3, 2035.

Sentiment

Score: 6

Explanation: The document reflects standard insider transactions (share disposal for tax obligations and option grant), which are neither particularly positive nor negative. It's a routine disclosure.

Positives

• The grant of share options to the Chief Business Officer aligns his interests with those of the shareholders.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the share options.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which is crucial for maintaining investor confidence. These filings are common across all publicly traded companies and are a routine part of corporate governance.

Comparison to Industry Standards

• Executive compensation packages, including share options, are a common practice in the pharmaceutical industry to incentivize performance and align executive interests with shareholder value.
• Companies like Amgen, Pfizer, and Novartis also utilize share options as part of their executive compensation plans.
• The vesting schedule and exercise price are typical for such grants, aligning with industry norms for incentivizing long-term performance.

Stakeholder Impact

• The disposal of shares to cover tax obligations has a minimal impact on shareholders.
• The granting of share options incentivizes the Chief Business Officer, potentially benefiting shareholders through improved company performance.

Key Dates